Overview

Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris

Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Comparison of the safety and efficacy of Tazarotene Cream 0.1% compared with Adapalene Gel 0.3% in treating moderate to severe facial acne vulgaris
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Adapalene
Nicotinic Acids
Tazarotene